会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Bundle of selectively permeable polysulfone-based hollow fiber membranes and process for manufacturing same
    • 选择性渗透性聚砜基中空纤维膜束及其制造方法
    • US20070114167A1
    • 2007-05-24
    • US10582052
    • 2004-12-08
    • Kimihiro MabuchiNoriyuki TamamuraHidehiko SakuraiNoriaki KatoHiroshi ShibanoKatsuhiko Nose
    • Kimihiro MabuchiNoriyuki TamamuraHidehiko SakuraiNoriaki KatoHiroshi ShibanoKatsuhiko Nose
    • B01D63/00
    • B01D69/08B01D67/009B01D67/0095B01D69/02B01D71/44B01D71/68B01D2323/02B01D2323/12B01D2323/30B01D2323/34
    • The present invention provides polysulfone-based hollow fiber membranes having high water permeable performance and for use in therapy of chronic renal failures, said hollow fiber membranes having high safety and high stability in performance and being excellent in module-fabricating workability. The present invention also provides a process for manufacturing the same. The present invention relates to a bundle of a plurality of selectively permeable polysulfone-based hollow fiber membranes wherein the amount of a hydrophilic polymer eluting from each hollow fiber membrane is not larger than 10 ppm, and wherein the content of the hydrophilic polymer in the outer surface of the hollow fiber membrane is 25 to 50 mass %, and this bundle is characterized in that any of extracted solutions from ten fractions of said bundle, obtained by dividing the bundle at substantially regular intervals along the lengthwise direction, shows a maximum value of smaller than 0.10 in UV absorbance at a wavelength of 220 to 350 nm, with the proviso that the extracted solutions are obtained by the extraction method for tests regulated in the approval manufacturing standards for dialytic artificial kidney devices; and in that the difference between the maximum and the minimum out of the maximum values of UV absorbance of the extracted solutions from the respective fractions is not larger than 0.05.
    • 本发明提供了具有高透水性的聚砜基中空纤维膜,用于治疗慢性肾功能衰竭,所述中空纤维膜具有高安全性和高性能稳定性,模块制造加工性优异。 本发明还提供一种制造该方法的方法。 本发明涉及多根选择性渗透性聚砜系中空纤维膜束,其中从各中空纤维膜洗出的亲水性聚合物的量不大于10ppm,其中亲水性聚合物在外层 中空纤维膜的表面为25〜50质量%,该束的特征在于,通过沿着长度方向以基本上规则的间隔分割束而获得的所述束的十个部分的提取液中的任何一个显示最大值 波长为220〜350nm时紫外吸光度小于0.10,条件是通过透析人造肾装置的认可制造标准规定的试验提取方法获得提取液; 并且来自各个馏分的萃取溶液的UV吸光度的最大值的最大值和最小值之间的差异不大于0.05。
    • 9. 发明申请
    • BLOOD PURIFIER
    • 血液净化器
    • US20090272686A1
    • 2009-11-05
    • US11910627
    • 2006-04-03
    • Kimihiro MabuchiHideyuki YokotaKatsuaki KuzeNoriko MondenNoriaki KatoMakoto OhnoMitsuru Suzuki
    • Kimihiro MabuchiHideyuki YokotaKatsuaki KuzeNoriko MondenNoriaki KatoMakoto OhnoMitsuru Suzuki
    • B01D69/08
    • B01D69/02A61M1/16A61M2209/06B01D67/0011B01D67/009B01D69/08B01D71/44B01D71/68B01D2325/20B01D2325/28C02F1/44C02F2103/026
    • [Purpose] To provide a blood purifier which has high levels of blood compatibility, performance-retaining property when in contact with blood, and safety, and which shows an excellent water permeability-exhibiting rate after a priming treatment and has high reliability in long-term storage.[Solution] A blood purifier assembled using a polyvinyl pyrrolidone-containing polysulfone-based permselective hollow fiber membrane bundle, characterized in that the amount of polyvinyl pyrrolidone which elutes from the hollow fiber membrane bundle is 10 ppm or less, the amounts of hydrogen peroxide which elute from extracts from all the sites of the hollow fiber membrane bundle are 5 ppm or less, when the hollow fiber membrane bundle is divided into 10 portions in the lengthwise direction to test the sites of all the 10 portions according to the method regulated in the Approval Standard for Dialysis-Type Artificial Kidney Apparatus, and the water permeability of the blood purifier found at a point of time when 10 minutes has passed since the priming treatment of the blood purifier is 90% or more of the water permeability of the same found at a point of time when 24 hours has passed since the priming treatment thereof.
    • [目的]提供一种具有高血液相容性,与血液接触时的性能保持性和安全性的血液净化器,并且在预处理后显示出优异的透水性,并且在长期使用中具有高可靠性, 长期存储。 [解决方案]使用含聚乙烯吡咯烷酮的聚砜系渗透性中空纤维膜束组装的血液净化器,其特征在于,从中空纤维膜束洗出的聚乙烯吡咯烷酮的量为10ppm以下,过氧化氢的量 从中空纤维膜束的所有位置的提取物中洗脱出的浓度为5ppm以下,将中空纤维膜束沿长度方向分割成10份,按照本发明的方法 透析型人造肾器的认可标准和自血液净化器起动处理10分钟后发现的血液净化器的透水性为同一发现的透水性的90%以上 在自启动处理24小时后的时间点。